Evaluation of an assay for serum 1,5-anhydroglucitol (GlycoMark™) and determination of reference intervals on the Hitachi 917 analyzer

Clinica Chimica Acta

Volumn 350, Issue 1-2, 2004, Pages 201-209

  Nowatzke, William ^a   Sarno, Mark J ^b   Birch, Nathan C ^c   Stickle, Douglas F ^c   Eden, Tanya ^d   Cole, Thomas G ^a  

^a Linco Diagnostics   (United States)

^b Vision Biotechnology Consulting   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

1,5 Anhydroglucitol; 1 Deoxyglucose; Biomarker; Diabetes; Hyperglycemic

Indexed keywords

1,5 ANHYDROSORBITOL; HEMOGLOBIN;

ADULT; ANALYZER; ARTICLE; BILIRUBIN BLOOD LEVEL; CORRELATION COEFFICIENT; DEVICE; DIABETES MELLITUS; DIAGNOSTIC VALUE; EVALUATION; FEMALE; FREEZING; HUMAN; HYPERGLYCEMIA; MALE; MEASUREMENT; NORMAL HUMAN; PERFORMANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; TEMPERATURE; THAWING; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

ADOLESCENT; AUTOANALYSIS; BILIRUBIN; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DEOXYGLUCOSE; DIABETES MELLITUS; ETHNIC GROUPS; FEMALE; HEMOGLOBINS; HUMANS; HYPERGLYCEMIA; IMMUNOASSAY; MALE; TEMPERATURE; TRIGLYCERIDES;

EID: 7644230144     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.08.013     Document Type: Article

References (29)

1. T. Yamanouchi, Y. Tachibana, H. Akanuma, S. Minoda, T. Shinohara, and H. Moromizato Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body Am. J. Physiol. 263 1992 268 273
2. H. Akanuma, K. Ogawa, Y. Lee, and Y. Akanuma Reduced levels of plasma 1,5-anhydroglucitol in diabetic patients J. Biochem. (Tokyo) 90 1981 157 162
3. D. Stickle, and J. Turk A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control Am. J. Physiol. 273 1997 821 830
4. E. Pitkanen Serum 1,5-anhydroglucitol in normal subjects and in patients with insulin-dependent diabetes mellitus Scand. J. Clin. Lab. Invest 42 1982 445 448
5. T. Yamanouchi, H. Akanuma, T. Asano, C. Konishi, I. Akaoka, and Y. Akanuma Reduction and recovery of plasma 1,5-anhydro-d-glucitol level in diabetes mellitus Diabetes 36 1987 709 715
6. T. Yamanouchi, H. Akanuma, T. Nakamura, I. Akaoka, and Y. Akanuma Reduction of plasma 1,5-anhydroglucitol (1-deoxyglucose) concentration in diabetic patients Diabetologia 31 1988 41 45
7. T. Yamanouchi, S. Minoda, M. Yabuuchi, Y. Akanuma, H. Akanuma, and H. Miyashita Plasma 1,5-anhydro-d-glucitol as new clinical marker of glycemic control in NIDDM patients Diabetes 38 1989 723 729
8. T. Yamanouchi, Y. Akanuma, T. Toyota, T. Kuzuya, T. Kawai, and S. Kawazu Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus Diabetes 40 1991 52 57
9. F. Umeda, T. Yamauchi, H. Ishii, N. Nakashima, A. Hisatomi, and H. Nawata Serum 1,5-anhydro-d-glucitol and glycemic control in patients with non-insulin-dependent diabetes mellitus Tohoku J. Exp. Med. 163 1991 93 100
10. T. Yamanouchi, and Y. Akanuma Serum 1,5-anhydroglucitol (1,5-AG): new clinical marker for glycemic control Diabetes Res. Clin. Pract. 24 1994 S261 S268 (suppl.)
11. S. Tsukui, Y. Fukumura, and I. Kobayashi Decreased serum 1,5-anhydroglucitol in nondiabetic subjects with a family history of NIDDM Diabetes Care 19 1996 940 944
12. E.S. Kilpatrick, B.G. Keevil, K.L. Richmond, P. Newland, and G.M. Addison Plasma 1,5-anhydroglucitol concentrations are influenced by variations in the renal threshold for glucose Diabet. Med. 16 1999 496 499
13. H. Shimizu, A. Shouzu, M. Nishikawa, S. Omoto, T. Hayakawa, and Y. Miyake Serum concentration and renal handling of 1,5-anhydro-d-glucitol in patients with chronic renal failure Ann. Clin. Biochem. 36 1999 749 754
14. M. Kishimoto, Y. Yamasaki, M. Kubota, K. Arai, T. Morishima, and R. Kawamori 1,5-Anhydro-d-glucitol evaluates daily glycemic excursions in well-controlled NIDDM Diabetes Care 18 1995 1156 1159
15. T. Yamanouchi, N. Ogata, T. Tagaya, T. Kawasaki, N. Sekino, and H. Funato Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control Lancet 347 1996 1514 1518
16. DCCT Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N. Engl. J. Med. 329 1993 977 986
17. Y. Tahara, and K. Shima Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level Diabetes Care 18 1995 440 447
18. S. Yoshioka, S. Saitoh, T. Fujisawa, A. Fujimori, O. Takatani, and M. Funabashi Identification and metabolic implication of 1-deoxyglucose (1,5-anhydroglucitol) in human plasma Clin. Chem. 28 6 1982 1283 1286
19. T. Niwa, N. Yamamoto, K. Maeda, K. Yamada, T. Ohki, and M. Mori Gas chromatographic-mass spectrometric analysis of polyols in urine and serum of uremic patients. Identification of new deoxyalditols and inositol isomers J. Chromatogr. 277 1983 25 39
20. Y. Fukumura, S. Tajima, S. Oshitani, Y. Ushijima, I. Kobayashi, and F. Hara Fully enzymatic method for determining 1,5-anhydro-d-glucitol in serum Clin. Chem. 40 1994 2013 2016
21. Lana® 1,5-AG Auto Liquid Package Insert 2000 (March) Nippon Kayaku Japan
22. NCCLS. Evaluation of Precision Performance of Clinical Chemistry Devices; Approved Guideline. NCCLS document EP5-A (ISBN 1-56238-368-X). NCCLS, 940 West Valley Road, Suite 1400, Wayne, PA 19087-1898, USA, 1999.
23. NCCLS. Evaluation of the linearity of quantitative analytical methods; Proposed Guideline. NCCLS Publication EP6-P. NCCLS, 940 West Valley Road, Suite 1400, Wayne, PA 19087-1898, USA, 1986.
24. NCCLS. Method Comparison and Bias Estimation Using Patient Samples. Approved Guideline. NCCLS document EP9-A (ISBN 1-56238-283-7). NCCLS, 940 West Valley Road, Suite 1400, Wayne, PA 19087-1898, USA, 1995.
25. NCCLS. How to Define and Determine Reference interval Intervals in the Clinical Laboratory. Approved Guideline. NCCLS document C28-A (ISBN 1-56238-143-1). NCCLS, 940 West Valley Road, Suite 1400, Wayne, PA 19087-1898, USA, 1995.
26. D.A. Robertson, G. Rafique, P. Robinson, K. Bartlett, and K.G. Alberti Serum anhydroglucitol as a diagnostic test for diabetes mellitus [abstract] Diabet. Med. 8 1991 22A
27. D.A. Robertson, K.G. Alberti, G.K. Dowse, P. Zimmet, J. Tuomilehto, and H. Gareeboo Is serum anhydroglucitol an alternative to the oral glucose tolerance test for diabetes screening? The Mauritius Noncommunicable Diseases Study Group Diabet. Med. 10 1993 56 60
28. W.H. Tam, M.S. Rogers, T.K. Lau, and M. Arumanayagam The predictive value of serum 1,5-anhydro-d-glucitol in pregnancies at increased risk of gestational diabetes mellitus and gestational impaired glucose tolerance BJOG 108 2001 754 756
29. J.B. McGill, T.G. Cole, W. Nowatzke, S. Houghton, E. Ammirati, and T. Gautille Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia Diabetes Care 27 8 2004 1859 1865